The Tumultuous Journey of Olaplex: From IPO Darling to Turnaround Challenge
When prestige hair care innovator Olaplex first rang the Nasdaq opening bell in late 2021, it embodied the fervor of a red-hot IPO market. Priced above initial guidance, shares launched at $25, quickly soaring to an all-time high of $29.41 in early January 2022. The brand, famed for its bond-building technology used by salons and consumers alike, seemed poised for relentless growth.
That peak, however, marked the beginning of a steep and sustained decline. Since its debut, Olaplex’s stock has lost nearly 95% of its value—a stark contrast to the S&P 500’s gain of over 50% in the same period. Today, shares trade below $1.50, giving the company a market capitalization of roughly $1 billion. The precipitous fall has left investors and industry observers questioning the brand’s path forward.
Unraveling: Demand, Lawsuits, and Social Media Firestorms
The initial slide in 2022 was attributed to softening consumer demand and broader economic pressures. The situation intensified dramatically in early 2023 when a lawsuit, later dismissed, alleged that Olaplex products containing the ingredient lilial caused hair loss and damage for nearly 30 plaintiffs. While Olaplex aggressively denied the claims and had already removed lilial from its formulations, the narrative spread virally across social media platforms. The reputational damage proved enduring, creating a headwind the company struggled to counter. For the full 2023 fiscal year, U.S. net sales plummeted 47.8% year-over-year, and net income dropped 74.8%.
Compounding these internal challenges was a rapidly densifying competitive landscape. Rival brands like K18, Ouai, and Redken aggressively captured market share with their own bond-repair and scalp-health offerings, filling the void as Olaplex grappled with its public crisis.
A New Chapter: Leadership and Strategic Reboot
Recognizing the need for a reset, Olaplex appointed Amanda Baldwin as CEO in late 2023. Baldwin, formerly at the helm of Supergoop, brought a mandate to revitalize the brand. “Olaplex stands apart as a category creator redefining what is possible through the combination of beauty and science,” she stated at the time, outlining plans to deepen customer engagement, drive innovation, and sharpen communications.
Her first move was a comprehensive rebranding effort. Internal research revealed that consumers perceived Olaplex as “effective, yet cold and clinical.” A subsequent brand health tracker showed measurable progress in making the brand appear “more approachable and alluring” while maintaining its scientific credibility. The company also launched new products, such as a pre-shampoo treatment, to advance its core bond-building technology and signal ongoing innovation.
Financial Signals: Modest Gains and Persistent Headwinds
Recent financial data presents a mixed picture. Olaplex’s fourth-quarter 2024 report showed a 4.3% year-over-year increase in net sales to $105.1 million, offering a glimmer of hope. However, full-year 2025 net sales grew a mere 0.1%, underscoring the fragility of the recovery. The tepid results sent shares down more than 20% post-earnings, reflecting investor skepticism.
JPMorgan Chase
